Polymyalgia Rheumatica: Steroids and Beyond : Lower doses of prednisone and a greater use of biologics are on the PMR treatment horizon.

In contrast, antitumor necrosis factor therapy using etanercept or infliximab has compiled an unimpressive record overall for PMR in case reports and pilot studies.

“At present, I think there is no role for antitumor necrosis factor therapy in PMR,” he said.

Disclosures: Dr. Cimmino disclosed having received research grants from numerous pharmaceutical companies, including Roche, Schering Plough, Abbott, and Pfizer.